We are live on ! Find out more
GNMK

GenMark Diagnostics, Inc
GNMK

Delisted

GNMK was delisted on the 21st of April, 2021.

Back to rankings

98 hedge funds and large institutions have $306M invested in GenMark Diagnostics, Inc in 2018 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 33 increasing their positions, 29 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

28% more capital invested

Capital invested by funds: $239M → $306M (+$66.8M)

14% more repeat investments, than reductions

Existing positions increased: 33 | Existing positions reduced: 29

8% less first-time investments, than exits

New positions opened: 11 | Existing positions closed: 12

1% less funds holding

Funds holding: 99 → 98 (-1)

Holders
98
Holders Change
-1
Holders Change %
-1.01%
% of All Funds
2.25%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
33
Reduced
29
Closed
12
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
CC
Casdin Capital
New York
+$5.57M
2
BG
Bellevue Group
Switzerland
+$2.05M
3
PI
Putnam Investments
Massachusetts
+$1.65M
4
PWP
Private Wealth Partners
California
+$1.49M
5
BCM
Bridgeway Capital Management
Texas
+$894K

Top Sellers

Rank Fund Capital Flow
1
Jennison Associates
Jennison Associates
New York
-$7.57M
2
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$3.48M
3
Millennium Management
Millennium Management
New York
-$2.7M
4
GTC
Ghost Tree Capital
New York
-$2.08M
5
Two Sigma Investments
Two Sigma Investments
New York
-$1.6M
Name Holding Trade Value Shares
Change 		Change in
Stake
GF
76
Gabelli Funds
New York
$56K +$51.5K +10,370 New
CC
77
Cannell & Co
New York
$54K – – –
Legal & General Group
78
Legal & General Group
United Kingdom
$51K -$17.2K -3,452 -27%
Canada Life
79
Canada Life
Manitoba, Canada
$40K – – –
TWA
80
TCI Wealth Advisors
Arizona
$37K – – –
Victory Capital Management
81
Victory Capital Management
Texas
$35K – – –
EMG
82
ETF Managers Group
New Jersey
$28K +$3.4K +684 +14%
IF
83
Ironwood Financial
Arizona
$25K +$4.79K +964 +27%
AIP
84
Ameritas Investment Partners
Nebraska
$20K – – –
PCM
85
Prelude Capital Management
New York
$18K +$13.2K +2,648 +441%
Bank of Montreal
86
Bank of Montreal
Ontario, Canada
$17K +$15.6K +3,133 New
LTFS
87
Ladenburg Thalmann Financial Services
Florida
$11K +$9.94K +2,000 New
First Manhattan
88
First Manhattan
New York
$10K +$9.94K +2,000 New
RE
89
RBC Europe
United Kingdom
$9.75K – – –
QCG
90
Quadrant Capital Group
Ohio
$8K +$7.46K +1,500 New
Zurich Cantonal Bank
91
Zurich Cantonal Bank
Switzerland
$7K – – –
UBS Group
92
UBS Group
Switzerland
$5K -$20K -4,029 -83%
GT
93
Glenmede Trust
Pennsylvania
$4K – – –
SIM
94
Sonora Investment Management
Arizona
$2.18K – – –
SSB
95
Sandy Spring Bank
Maryland
$2K – – –
Citigroup
96
Citigroup
New York
$1K -$855 -172 -40%
CAC
97
Certified Advisory Corp
Florida
$1K – – –
GTC
98
Ghost Tree Capital
New York
– -$2.08M -500,000 Closed
Allianz Asset Management
99
Allianz Asset Management
Germany
– -$1.14M -273,636 Closed
Susquehanna International Group
100
Susquehanna International Group
Pennsylvania
– -$74K -17,729 Closed
1 2 3
4
5

GNMK Hedge Fund Activity: Q1 2018 in Review

98 of the 4,364 institutional investors tracked by Wall St. Rank reported a position in GenMark Diagnostics, Inc (GNMK) for Q1 2018, worth a combined $306M — up 28% from $239M a quarter earlier.

Sellers outnumbered buyers: 12 funds closed out of GNMK and 11 opened new positions — a net loss of 1 holder — while 29 trimmed existing stakes and 33 added.

The largest buyer was Casdin Capital, adding an estimated $5.57M. The largest seller was Jennison Associates, cutting an estimated $7.57M.

  • 98 institutional investors held GenMark Diagnostics, Inc (GNMK) as of Q1 2018, down from 99 in Q4 2017.
  • Funds reported $306M of GenMark Diagnostics, Inc stock for Q1 2018, up 28% quarter-over-quarter.
  • 11 funds opened new GenMark Diagnostics, Inc positions in Q1 2018 and 12 closed out, a net change of -1 holder.
  • The largest GenMark Diagnostics, Inc buyer in Q1 2018 was Casdin Capital, an estimated $5.57M added.
  • The largest GenMark Diagnostics, Inc seller in Q1 2018 was Jennison Associates, an estimated $7.57M sold.

Based on aggregated 13F filings for Q1 2018.